Taxus Cardium Pharmaceuticals Group Inc

(CRXM)

By |

Profile

Gene Biotherapeutics Inc, formerly known as Taxus Cardium Pharmaceuticals Group Inc is an operating company which manages medical technologies portfolio. Its investment portfolio includes Angionetics, which focuses on late-stage clinical development and commercialization of Generx, an angiogenic gene therapy product candidate designed for medical treatment of myocardial ischemia and refractory angina; Activation Therapeutics focuses on the development and commercialization of the Excellagen, which is a flowable dermal matrix technology platform for small molecule drugs, proteins, and biologics.

Contact Information

Website: www.genebiotherapeutics.com
Email: investorrelations@cardiumthx.com
Main Phone: +1 858 436-1000
Address: 11568 Sorrento Valley Road
Address 2: Suite 14
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92121

Issuer Information

Exchange: OTO
CEO: Christopher J. Reinhard
Employees: 6
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 0.066 $ 0. (0.00%)
Last Price 0.066 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.062 High 0.07 Low 0.062 Prev Close 0.066
Last Trade Volume 3,600 52 Wk Hi 0.13 52 Wk Low 0.05
Market Cap 948,654 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 14,373,544.00 EPS (TTM) -0.30 PE Ratio N/A Exchange OTCPK
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 2 2 2 2
Low Target Price Estimate 2 2 2 2
Mean Target Price Estimate 2 2 2 2
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 03/10/14 03/10/14 03/10/14 03/10/14
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1